| human | Q5 |
| P496 | ORCID iD | 0000-0003-4624-031X |
| P108 | employer | Karolinska Institutet | Q219564 |
| P735 | given name | Maria | Q325872 |
| Maria | Q325872 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q33761618 | A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants |
| Q44576506 | A novel prefractionation method combining protein and peptide isoelectric focusing in immobilized pH gradient strips |
| Q37398798 | Affinity prefractionation for MS-based plasma proteomics |
| Q33262046 | Annotated regions of significance of SELDI-TOF-MS spectra for detecting protein biomarkers |
| Q21090550 | Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions |
| Q30664020 | Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value |
| Q38583728 | ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing |
| Q91235996 | Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model |
| Q33953287 | Enhanced information output from shotgun proteomics data by protein quantification and peptide quality control (PQPQ). |
| Q112579059 | Evaluation of Spin Columns for Human Plasma Depletion to Facilitate MS-Based Proteomics Analysis of Plasma |
| Q33343239 | Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery. |
| Q35963234 | Identifying and Assessing Interesting Subgroups in a Heterogeneous Population. |
| Q64066504 | In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta |
| Q38198753 | Mass spectrometry-based plasma proteomics: state of the art and future outlook |
| Q112581404 | Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin |
| Q38396986 | Molecular histology of lung cancer: from targets to treatments |
| Q34411128 | Network enrichment analysis: extension of gene-set enrichment analysis to gene networks |
| Q36824030 | Protein Z: A putative novel biomarker for early detection of ovarian cancer |
| Q31154286 | Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia |
| Q38456643 | Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages |
| Q33613608 | Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance. |
| Q43687772 | Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism |
| Q42358221 | Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells. |
| Q38157427 | The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets |
| Q64286426 | The viral protein corona directs viral pathogenesis and amyloid aggregation |
| Q38289312 | Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer |
| Q91209309 | Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma |
| Q40085596 | Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling |
| Q39824178 | Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion |
Search more.